Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Cancer Immunotherapy: The Optogenetics Angle

    Article obtained from Optics and Photonics News RSS Feed.

    Ongoing research in “optoimmunoengineering” may help to extend the impact of Nobel Prize–winning work.

    READ MORE
    Oct, 01 2018 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.